Researchers have devised and validated an 11-gene expression test that can distinguish patients with stage I or II lung cancer who have a low, intermediate, or high risk for having micrometastatic disease after primary tumor resection that requires adjuvant chemotherapy. Dr. Johannes Kratz discusses the test.

The University of Maryland Greenebaum Cancer Center has opened a new Phase I/IIa clinical trial for multiple myeloma. The trial is designed to investigate the safety, bioactivity and anti-tumor effect of infusion of patients' own T cells that have been genetically modified to express a high affinity T cell receptor (TCR) specific for a type of tumor antigen (protein) known as a cancer testis antigen (CT antigen).

London is among 9 Canadian cities to study a new way to detect oral cancer. It's a groundbreaking procedure that could give patients a better chance for survival.
London is among 9 Canadian cities to study a new way to detect oral cancer. It's a groundbreaking procedure that could give patients a better chance for survival.